investorscraft@gmail.com

Intrinsic Value of DENTSPLY SIRONA Inc. (XRAY)

Previous Close$16.00
Intrinsic Value
Upside potential
Previous Close
$16.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

DENTSPLY SIRONA Inc. operates as a global leader in the dental consumables, equipment, and technology sector, serving dental professionals through a diversified portfolio of products and solutions. The company generates revenue primarily through the sale of dental implants, orthodontic appliances, imaging systems, and CAD/CAM solutions, catering to both general practitioners and specialists. Its market position is reinforced by a strong distribution network and strategic partnerships, enabling broad geographic reach and customer loyalty. DENTSPLY SIRONA competes in a fragmented but growing industry, driven by increasing demand for advanced dental care and digital dentistry solutions. The company’s focus on innovation, particularly in digital workflows and restorative materials, positions it as a key player in the transition toward more efficient and patient-centric dental practices. Despite competitive pressures, its established brand and comprehensive product suite provide a competitive edge in both developed and emerging markets.

Revenue Profitability And Efficiency

In FY 2024, DENTSPLY SIRONA reported revenue of $3.79 billion, reflecting its scale in the dental industry. However, the company posted a net loss of $910 million, with diluted EPS of -$4.48, indicating significant challenges in profitability. Operating cash flow stood at $461 million, suggesting underlying operational efficiency, while capital expenditures of $180 million highlight ongoing investments in innovation and infrastructure.

Earnings Power And Capital Efficiency

The company’s negative earnings power in FY 2024 underscores operational headwinds, likely tied to restructuring costs or macroeconomic pressures. Free cash flow, calculated as operating cash flow minus capital expenditures, was $281 million, demonstrating some ability to generate liquidity despite profitability struggles. Capital efficiency metrics remain under scrutiny given the net loss and high debt levels.

Balance Sheet And Financial Health

DENTSPLY SIRONA’s balance sheet shows $272 million in cash and equivalents against total debt of $2.27 billion, indicating a leveraged position. The debt-to-equity ratio suggests financial risk, though operating cash flow provides some coverage. Investors should monitor debt servicing capabilities, especially if profitability does not improve in the near term.

Growth Trends And Dividend Policy

Growth trends appear muted given the FY 2024 net loss, though the dental industry’s long-term prospects remain favorable. The company maintained a dividend of $0.64 per share, signaling commitment to shareholder returns despite earnings challenges. Future dividend sustainability will depend on profitability recovery and free cash flow generation.

Valuation And Market Expectations

Market expectations for DENTSPLY SIRONA likely reflect skepticism due to its FY 2024 losses. Valuation metrics may be depressed, with investors awaiting signs of turnaround. The stock’s performance will hinge on execution of cost-saving initiatives, demand for digital dentistry solutions, and broader macroeconomic conditions affecting dental spending.

Strategic Advantages And Outlook

DENTSPLY SIRONA’s strategic advantages include its global footprint, diversified product portfolio, and leadership in digital dentistry. The outlook depends on its ability to restore profitability, manage debt, and capitalize on industry tailwinds like aging populations and technological adoption. Success in these areas could reposition the company for sustainable growth.

Sources

Company filings, FY 2024 financial data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount